TABLE OF CONTENTS
Chapter 1 Prefix
1.1 Market Scope
1.2 Report Description
1.3 Research Methodology
1.3.1 Primary Research
1.3.2 Secondary Research
1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
2.1 Global Multiple Myeloma Therapeutics Market Year-on-Year Growth, 2020 – 2028 (%)
Chapter 3 Market Outline
3.1 Market Inclination, Trend, Outlook, and Viewpoint
3.2 Market Share Analysis: Company’s Competitive Scenario
3.3 Value Chain Analysis
3.4 Porter’s Five Forces Analysis
3.5 Market Dynamics
3.5.1 Drivers
3.5.1.1 Impact Analysis
3.5.2 Restraints
3.5.2.1 Impact Analysis
3.5.3 Opportunities
Chapter 4 Global Multiple Myeloma Therapeutics Market by Treatment: Market Size and Forecast, 2019 – 2028
4.1 Overview
4.2 Proteasome Inhibitor
4.2.1 Current Trend and Analysis
4.2.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
4.2.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
4.3 CD38
4.3.1 Current Trend and Analysis
4.3.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
4.3.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
4.4 Immunomodulators
4.4.1 Current Trend and Analysis
4.4.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
4.4.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
4.5 Alkylating Agents
4.5.1 Current Trend and Analysis
4.5.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
4.5.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
4.6 Others
4.6.1 Current Trend and Analysis
4.6.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
4.6.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
Chapter 5 Global Multiple Myeloma Therapeutics Market by Distribution Channel: Market Size and Forecast, 2019 – 2028
5.1 Overview
5.2 Hospital Pharmacy
5.2.1 Current Trend and Analysis
5.2.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
5.2.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
5.3 Retail Pharmacy
5.3.1 Current Trend and Analysis
5.3.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
5.3.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
5.4 Drug Store
5.4.1 Current Trend and Analysis
5.4.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
5.4.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
5.5 Online Sales
5.5.1 Current Trend and Analysis
5.5.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
5.5.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)
Chapter 6 Global Multiple Myeloma Therapeutics Market by Geography: Market Size and Forecast, 2019 - 2028
6.1 Overview
6.1.1 Global Multiple Myeloma Therapeutics Market Year-on-Year Growth, by region 2020 – 2028 (%)
6.2 North America
6.2.1 Current Trend and Analysis
6.2.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.2.3 U.S.
6.2.3.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.2.3.2 By Treatment
6.2.3.3 By Distribution Channel
6.2.4 Canada
6.2.4.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.2.4.2 By Treatment
6.2.4.3 By Distribution Channel
6.2.5 Mexico
6.2.5.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.2.5.2 By Treatment
6.2.5.3 By Distribution Channel
6.3 Europe
6.3.1 Current Trend and Analysis
6.3.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.3 UK
6.3.3.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.3.2 By Treatment
6.3.3.3 By Distribution Channel
6.3.4 Russia
6.3.4.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.4.2 By Treatment
6.3.4.3 By Distribution Channel
6.3.5 France
6.3.5.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.5.2 By Treatment
6.3.5.3 By Distribution Channel
6.3.6 Italy
6.3.6.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.6.2 By Treatment
6.3.6.3 By Distribution Channel
6.3.7 Germany
6.3.7.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.7.2 By Treatment
6.3.7.3 By Distribution Channel
6.3.8 Rest of Europe
6.3.8.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.3.8.2 By Treatment
6.3.8.3 By Distribution Channel
6.4 Asia-Pacific
6.4.1 Current Trend and Analysis
6.4.2 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.4.3 China
6.4.3.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.4.3.2 By Treatment
6.4.3.3 By Distribution Channel
6.4.4 India
6.4.4.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.4.4.2 By Treatment
6.4.4.3 By Distribution Channel
6.4.5 Japan
6.4.5.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.4.5.2 By Treatment
6.4.5.3 By Distribution Channel
6.4.6 Rest of Asia-Pacific
6.4.6.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.4.6.2 By Treatment
6.4.6.3 By Distribution Channel
6.5 RoW
6.5.1 Current Trend and Analysis
6.5.2 Market Size and Forecast
6.5.3 South America
6.5.3.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.5.3.2 By Treatment
6.5.3.3 By Distribution Channel
6.5.4 Middle East
6.5.4.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.5.4.2 By Treatment
6.5.4.3 By Distribution channel
6.5.5 Africa
6.5.5.1 Market Size and Forecast, 2019 - 2028 ($ Billion)
6.5.5.2 By Treatment
6.5.5.3 By Distribution channel
Chapter 7 Company Profiles
7.1 CELGENE CORPORATION (Bristol Myers Squibb Company).
7.1.1 Company Overview
7.1.2 Product Portfolio
7.1.3 Business Strategies
7.1.4 Financials
7.1.5 Recent Developments
7.2 Takeda Pharmaceutical Company Limited.
7.2.1 Company Overview
7.2.2 Product Portfolio
7.2.3 Business Strategies
7.2.4 Financials
7.2.5 Recent Developments
7.3 Sanofi.
7.3.1 Company Overview
7.3.2 Product Portfolio
7.3.3 Business Strategies
7.3.4 Financials
7.3.5 Recent Developments
7.4 Novartis AG
7.4.1 Company Overview
7.4.2 Product Portfolio
7.4.3 Business Strategies
7.4.4 Financials
7.4.5 Recent Developments
7.5 ONO PHARMACEUTICAL CO., LTD.
7.5.1 Company Overview
7.5.2 Product Portfolio
7.5.3 Business Strategies
7.5.4 Financials
7.5.5 Recent Developments
7.6 AbbVie Inc.
7.6.1 Company Overview
7.6.2 Product Portfolio
7.6.3 Business Strategies
7.6.4 Financials
7.6.5 Recent Developments
7.7 Kayopharm.
7.7.1 Company Overview
7.7.2 Product Portfolio
7.7.3 Business Strategies
7.7.4 Financials
7.7.5 Recent Developments
7.8 Amgen Inc.
7.8.1 Company Overview
7.8.2 Product Portfolio
7.8.3 Business Strategies
7.8.4 Financials
7.8.5 Recent Developments
7.9 Janssen Pharmaceuticals, Inc.
7.9.1 Company Overview
7.9.2 Product Portfolio
7.9.3 Business Strategies
7.9.4 Financials
7.9.5 Recent Developments
7.10 Others.
7.10.1 Company Overview
7.10.2 Product Portfolio
7.10.3 Business Strategies
7.10.4 Financials
7.10.5 Recent Developments
Payment Options